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Introduction: In 2011 patients referred with suspected colorectal cancer
at our institution waited a median of 36 days (IQR 28-46) for a decision to
treat. We aimed to reduce this waiting time.
Methods: Quality improvement methodology was employed to change
our existing clinic-ﬁrst service to a straight-to-test service. Our nurse-led
telephone triage service conﬁrmed symptoms and assessed ﬁtness for
colonoscopy, with higher-risk patients defaulting to ﬂexible sigmoidos-
copy or clinic.
Results: 438 patients were referred between 1/10/2012 and 1/10/2013. 217
went straight to colonoscopy and 136 to ﬂexible sigmoidoscopy, 46went to
clinic, 31 patients DNA'd and data was missing for 8 patients. Diagnoses
were colorectal cancer (14), non-colorectal cancers (4), normal (111) and
benign conditions (224). Median time to decision to treat was 25 days (IQR
20-34), a signiﬁcant reduction (p¼0.01). 41/66 (62%) of patients with a
normal colonoscopy were discharged directly from endoscopy.
Conclusions: The new straight to endoscopy pathway was associated with
an average reduction of 11 days in making a decision to treat. Appoint-
ments were saved in 88% of new patients and in 62% of thosewith a normal
colonoscopy.
0702: RE-ADMISSION FOLLOWING APPENDICECTOMY: THE ROLE OF
MISDIAGNOSIS
Ben Rymer*, Mark Watson. Darent Valley Hospital, Dartford, UK.
Introduction: To investigate the cause for a higher-than-peer readmission
rate following appendicectomy at a district general hospital.
Methods: CHKS database was used to identify all patients re-admitted
following appendicectomy within 30 days between April and November
2013. Data were gathered from CHKS database, discharge summaries and
case notes. Initial appendix pathology was reviewed.
Results: Between April and November 2013, 143 patients underwent ap-
pendicectomy with 13.2% (n¼19) readmitted within 30 days. This
compared with 7.9% in the peer cohort. Twelve patients had acute
appendiceal pathology, conﬁrmed by macroscopic appearance, histology
or radiological ﬁndings. All twelve had raised inﬂammatory markers on
admission. The main reasons for readmission in this group were wound
infection (n¼4) or post-op pain (n¼3). In ﬁve cases, no acute pathology
was found on histology. Of these, 80% had normal inﬂammatory markers
on admission. Related readmission in this group was due to post-op pain
(n¼2) or wound infection (n¼1).
Conclusions: A signiﬁcant number of patients (26%) readmitted following
appendicectomy had no acute pathology at initial operation. Recognised
post-operative complications led to these patients being readmitted.
Higher pre-operative diagnostic certainty would reduce unnecessary ap-
pendectomies and subsequently reduce readmissions. Inﬂammatory
markers on admission were predictive of ﬁnal diagnosis in this cohort.
0724: DEFUNCTIONING LOOP ILEOSTOMY IN RECTAL CANCER SURGERY
e HELP OR HINDRANCE?
Olga Rutka*, Meera Ramcharn, Gethin Williams, Keshav Swarnkar. Royal
Gwent Hospital, Newport, UK.
Introduction: To analyse incidence of ileostomy formation during anterior
resection, outcomes of these operations as well as to audit the rate of
reversal of loop ileostomies.
Methods: A prospective database of all patients undergoing elective
anterior resection for rectal cancer from January 2007 to December 2011
was interrogated. Outcome measures were: use of neoadjuvant therapy,
length of hospital stay (LOS), complications, anastomotic leak, reversal rate
and length of follow up.
Results: 131 patients underwent anterior resection. Fifty ﬁve patients
(42%) had a loop ileostomy fashioned, of these 55 patients 65% (n¼36) had
neoadjuvant therapy. Mean LOS for a patient with loop ileostomy was 13
days and for those without 12 days. The morbidity rate for patients with
loop ileostomy was higher than in those without (24% vs. 19%). There was
no signiﬁcant difference in an anastomotic leak between groups (7.3% vs.
6.6%). There was one case of 30 day mortality in group without ileostomy.
Out of 55 fashioned ileostomies only 69% (n¼38) have been reversed.
Conclusions: Most loop ileostomies are fashioned in patients that have
undergone neoadjuvant therapy. Vast numbers of loop ileostomies (31%)are not being reversed. It is still not clear when to omit loop ileostomy in
rectal resection.
0734: ACCURATE LESION LOCALISATION AT COLONOSCOPY: AN ANAL-
YSIS OF POTENTIAL INFLUENCING FACTORS
A.S. Bryce*,1, S.J. Moug 2, M.S. Johnstone 1. 1University of Glasgow, Glasgow,
UK; 2Royal Alexandra Hospital, Paisley, UK.
Introduction: In this modern surgical era of laparoscopic resections and
cancer screening, the accuracy of colonoscopy for pre-operatively localising
colorectal tumours has taken on a new importance. This prospective study
aimed to elucidate factors which potentially inﬂuence this accuracy.
Methods: Patients who underwent surgical resection for a colorectal
tumour were recruited from ﬁve centres. To determine localisation accu-
racy, tumour location as reported by colonoscopy and radiological imaging
was compared with “true” (intra-operative) location. Also recorded were
patient and colonoscopic data.
Results: Tumour location at colonoscopy matched true location in 88 of
111 patients (79.3%). If patient BMI was  27.0 kg/m2 and if colonoscopy
was completed, colonoscopic localisation was more accurate (p<0.05).
Combination of eight bowel segments into three “super-segments”
revealed decreased localisation accuracy in tumours localised from sig-
moid colon to hepatic ﬂexure, in comparison to those localised to rectum,
and ascending colon to caecum (p<0.05).
Conclusions: This study adds information to a topic whose coverage
thus far has been sparse. The observations of increased likelihood of
inaccurate localisation (p<0.05) when colonoscopy is incomplete, patient
BMI is< 27.0 kg/m2, or a tumour is colonoscopically localised from sigmoid
colon to hepatic ﬂexure may be worth carrying forward to clinical practice.
0740: THE IMPACT OF INTRAVENOUS BUSCOPAN ON POLYP DETECTION
RATES AND PATIENT DISCOMFORT LEVELS DURING COLONOSCOPY
Qamar Zaman*,1, Aftab Khan 2, Daniel Thomas 1, Rajab Kerwat 1,
Hamid Khawaja 1, John Payne 1. 1Queen Mary Hospital, Sidcup, UK;
2University College London, London, UK.
Introduction: Hyoscine Butylbromide (Buscopan, Boehringer Ingelheim)
is sometimes administered intravenously during colonoscopy to relief
patients discomfort and/or improve diagnostic yield. In this study we
investigate the impact of intravenous Buscopan on polyp detection rates
and patient discomfort levels during colonoscopy.
Methods: We undertook a retrospective review of all colonoscopy reports
with completed data during the period January 2008 till June 2013 at our
institution. We compared the polyp detection rate and patient discomfort
levels with and without administration of intravenous Buscopan.
Results: A total of 7092 colonoscopieswereundertakenduring studyperiod.
Therewas F:M 1.25:1, median age 63 years (IQR 50-73). Buscopanwas given
to 30.1% of total patients and 90% of those received an average dose of 20mg.
Polyps were detected in 19.2% patients. The patient discomfort levels were
none¼52%, minimum¼10.2%, mild¼29.5% and moderate¼8.2%. On univar-
iate analysis, there was only modest statistical difference in polyp detection
rate (p0.057), but signiﬁcant inﬂuenceonpatient discomfort levels (p 0.004)
with additional use of Buscopan. Multivariate analysis showed signiﬁcant
improvement in polyp detection (0.007) and patient discomfort levels (p
<0.001) with addition of Buscopan during colonoscopy.
Conclusions: Buscopan is an important adjunct to improve polyp detec-
tion rates and patient discomfort levels during colonoscopies.
0770: AUDIT ON ELECTIVE COLORECTAL SURGERY IN THE ULSTER HOS-
PITAL
Dorothy Johnston*, Bill Campbell, Peter McGarrity, Jonathan McCarter,
Ian McAllister. Ulster Hospital, Dundonald, UK.
Introduction: To examine the outcomes of patients undergoing major
colorectal resections in thisunit as compared tooutcomes fromtheNational
Bowel Cancer Audit and the Association of Coloproctology guidelines.
Method: Data was gathered retrospectively with patients identiﬁed using
ICD-10 coding for major colorectal resections.
69 patients were identiﬁed over the time period of April to September
2013 and were followed up for 30 days post-operatively.
Complications were rated using the Clavien-Dindo scoring system.
Results: We found that of 39 males and 30 females 65% underwent open
resection and the remainder laparoscopic.
